| 381 | Pharmacological characterization of novel Store-Operated Calcium Entry Modulators
Biocotino I., Riva B., Pirali T., Genazzani AA. |
| 508 | Amyotrophic Lateral Sclerosis: Modification of Biophysical Properties and Gene Expression in Skeletal Muscle of a SOD-1 Related Mouse Model
Fonzino A., Conte E., Liantonio A., Camerino GM., Mele A., Tricarico D., Dobrowolny G., Musarò A., Conte Camerino D., Pierno S. |
| 516 | N-substituted tryptamines as TRPM8 channel modulators
Mosca I., Ambrosino P., Ostacolo C., Soldovieri MV., Campiglia P., Taglialatela M., Bertamino A., Gomez-Monterrey I. |
| 522 | The sensitivity of myotonia congenita hClC-1 mutants to 9-AC provides insight into the structure-function relationship and pharmacological modulation of hClC-1 channels
Altamura C., Imbrici P., Toscano A., Mantegazza R., Lo Monaco M., Desaphy JF., Conte Camerino D. |
| 565 | Identification of different splicing variants of Kv7.4 potassium channels in the F11 neuronal cell line
Medoro A., Soldovieri MV., Vinciguerra I., Taglialatela M. |
| 638 | Functional characterization of a novel mutation affecting the first Arginine in the S4 segment of Kv7.2 channel causing Early-Onset Epileptic Encephalopathy
Miceli F., Soldovieri MV., Ambrosino P., Cooper EC., Taglialatela M. |
| 639 | Biochemical, morphological, and pharmacological evidence for Kv7.4 channels expression in neuronal mitochondria
Vinciguerra I., Soldovieri MV., Paventi G., Ambrosino P., Calderone V., Passarella S., Taglialatela M. |
| 642 | Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits
De Maria M., Miceli F., Soldovieri MV., Ambrosino P., Migliore R., Migliore M., Taglialatela M. |
| 648 | Pharmacological rescue of KCNQ2 channels carrying Early-Onset Epiletic Encephalopathy mutations
Soldovieri MV., Ambrosino P., De Maria M., Mosca I., Miceli F., Striano P., Weckhuysen S., Cooper EC., Taglialatela M. |
| 499 | Clinical, molecular and functional characterization of a novel CLCN1 mutation associated to myotonia congenita
Imbrici P., Camerino GM., Altamura C., Mantegazza R., Siciliano G., Desaphy JF., Conte Camerino D. |
| 85 | MEL55A is a novel blocker of hyperpolarization-activated (HCN) channels with isoform selectivity and therapeutic potential in the pain axis
Dini L., Del Lungo M ., Resta F., Romanelli MN., Sartiani L., Mugelli A., Cerbai E. |
